Five-year clinical follow-up after sirolimus-eluting stent implantation for the treatment of coronary in-stent restenosis

Coronary Artery Disease

Volumn 22, Issue 3, 2011, Pages 188-193

  Schiele, Thomas M ^a,b   Leibig, Marcus ^a   Rieber, Johannes ^a   König, Andreas ^a   Krötz, Florian ^a   Sohn, Hae Young ^a   Klauss, Volker ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary artery disease; drug eluting stent; long term outcome; percutaneous coronary angioplasty; restenosis

Indexed keywords

CYPHER; FIBRINOGEN RECEPTOR ANTAGONIST; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY IN-STENT RESTENOSIS; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; THROMBOSIS;

EID: 79955059822     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283423714     Document Type: Article

References (25)

1. Bauters C, Banos JL, Van Belle E, Mc Fadden EP, Lablanche JM, Bertrand ME. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998; 97:318-321. (Pubitemid 28074331)
2. Mahdi NA, Pathan AZ, Harrell L, Leon MN, Lopez J, Butte A, et al. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J Cardiol 1998; 82:1345-1351. (Pubitemid 28565320)
3. Mehran R, Dangas G, Mintz GS, Waksman R, Abizaid A, Satler LF, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation 2000; 101:2484-2489. (Pubitemid 30366252)
4. Dietz U, Rupprecht H, De Belder M,Wijns W, Quarles van Ufford MA, Klues HG, et al. Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST). Am J Cardiol 2002; 90:843-847.
5. SerruysPW, LuijtenHE, BeattKJ, GeuskensR, De Feyter PJ,Van den BrandM, et al. Incidence of restenosis after successful coronary angioplasty: a timerelated phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77:361-371. (Pubitemid 18060045)
6. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12:616-623.
7. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000; 101:360-365. (Pubitemid 30067390)
8. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Fiveyear clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002; 105:2737-2740. (Pubitemid 34615144)
9. Waksman R, Ajani AE, White RL, Chan R, Bass B, Pichard AD, et al. Fiveyear follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004; 109:340-344. [Epub 19 January 2004]. (Pubitemid 38133901)
10. Schiele TM, Pö llinger B, Kantlehner R, Rieber J, Kö nig A, Seelig V, et al. Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions. Am J Cardiol 2004; 93:836-842. (Pubitemid 38429593)
11. Silber S, Popma JJ, Sunthalaringam M, Lansky AJ, Heuser RR, Speiser B, et al. Two-year clinical follow-up of 90Sr/90Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J 2005; 149:689-694.
12. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional IVUS study. Circulation 2003; 107:24-27. (Pubitemid 36070927)
13. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, Van der Giessen WJ, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003; 107:559-564. (Pubitemid 36176804)
14. Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA, et al. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after VBT. Am J Cardiol 2003; 92:200-203. (Pubitemid 36835971)
15. Radke PW, Kobella S, Kaiser A, Franke A, Schubert D, Grube E, et al. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. Eur Heart J 2004; 25:920-925. (Pubitemid 38857865)
16. Schiele TM, Kö nig A, Rieber J, Erhard I, Leibig M, Theisen K, et al. Sirolimuseluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions-comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Am Heart J 2005; 150:351-357. (Pubitemid 41116263)
17. Iofina E, Radke PW, Skurzewski P, Haager PK, Blindt R, Koch KC, et al. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison. Heart 2005; 91:1584-1589. (Pubitemid 41697601)
18. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005; 111: 2107-2111. (Pubitemid 40577906)
19. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. The SISR randomized trial. J Am Med Assoc 2006; 295:1264-1273.
20. Stone GW, Ellis SG, O'shaughnessy CD, Martin SL, Satler L, McGarry T, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. The TAXUS V ISR randomized trial. J Am Med Assoc 2006; 295:1253-1263.
21. Kastrati A, Mehilli J, Von Beckerath N, Dibra A, Hausleiter J, Pache J, et al.; ISAR-DESIRE study Investigators. Sirolimus-eluting stent or paclitaxeleluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. A randomized controlled trial. J Am Med Assoc 2005; 293:165-171. (Pubitemid 40095867)
22. Schukro C, Syeda B, Kirisits C, Schmid R, Pichler P, Pokrajac B, et al. Randomized comparison between intracoronary β-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol 2007; 82:18-23. (Pubitemid 46110909)
23. Ellis SG, O'shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, et al.; TAXUS V ISR Investigators. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J 2008; 29:1625-1634. [Epub 13 June 2008]. (Pubitemid 351958446)
24. Holmes DR Jr, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, et al. SISR investigators: 3-year follow-up of the SISR (sirolimus-eluting stents versus vascular brachytherapy for in-stent restenosis) trial. J Am Coll Cardiol Intv 2008; 1:439-448.
25. Alfonso F, Pérez-Vizcayno MJ, Hernández R, Bethencourt A, Martí V, Ló pez-Mínguez JR, et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intrastent: balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol 2008; 52:1621-1627.